Alixorexton boosts wakefulness in type 1 narcolepsy, shows cognitive and fatigue gains, and hints at ADHD and neurodegenerative uses.
David Plante, MD, PhD
Advertisement
Articles by David Plante, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
2
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
3
“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media
4
Monoamines: A Full House
5